55
Views
0
CrossRef citations to date
0
Altmetric
Original

Efficacy and Tolerability of Budesonide Clickhaler® and Turbuhaler® in Adult Asthma

, , &
Pages 697-703 | Published online: 02 Jul 2009

References

  • Asthma: A Concern for Minority Populations. National Institute of Allergy and Infectious Diseases. Available: http://www.niaid.nih.gov/factsheets/asthma.htm [accessed May 2004].
  • National Asthma Campaign Asthma Audit. Out in the open: a true picture of asthma in the United Kingdom today.The Asthma Journal 2001; 6(3):1–14. Available: http://www.asthma.org.uk/about/images/audit01.pdf. [CSA]
  • Global Initiative for Asthma. Publication No.: 95-3659. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute, 1995. Workshop update 2004.
  • British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Revised ed. April 2004. Available: http://www.brit-thoracic.org.uk/guidelines.html.
  • Engel T, Scharling B, Skovsted B, Heinig J H. Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from a dry powder inhaler device at different inhalation flows and volumes.Br J Clin Pharmacol 1992; 33(4):439–444. [PUBMED], [INFOTRIEVE], [CSA]
  • Borgström L, Bondesson E, Morén F, Trofast E, Newman S P. Lung deposition of budesonide inhaled via Turhuhaler®: a comparison with terbutaline sulphate in normal subjects.Eur Respir J 1994; 7(1):69–73. [CSA], [CROSSREF]
  • De Boeck K, Alifier M, Wamier G. Is the correct use of a dry powder inhaler (Turbohaler) age dependent?. J Allergy Clin Immunol 1999; 103(5):763–767. [PUBMED], [INFOTRIEVE], [CSA]
  • Chapman K R, Love I, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects.Chest 1993; 104(5):1332–1337. [PUBMED], [INFOTRIEVE], [CSA]
  • Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to medicinal products for human use. [CSA]
  • Clinical development of drugs against asthma. Society of Pharmaceutical Medicine Expert Report.J Pharm Med 1993; 3(3/4):193–205. [CSA]
  • Rogers D F, Ganderton D. Determining equivalence of inhaled medications.Respir Med 1995; 89(4):253–261. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Jain P, Kavuru M S, Emerman C L, Ahmad M. Utility of peak expiratory flow monitoring.Chest 1998; 114(3):861–876. [PUBMED], [INFOTRIEVE], [CSA]
  • Janson-Bjerklie S, Ferketich S, Benner P, Becker G. Clinical markers of asthma severity and risk: importance of subjective as well as objective factors.Heart Lung J Acute Crit Care 1992; 21(3):265–272. [CSA]
  • Brogden R N, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis.Drugs 1992; 44(3):375–407. [PUBMED], [INFOTRIEVE], [CSA]
  • Parry-Billings M, Boyes R N, Clisby L M, Braithwaite P, Williams S, Harper A E. Design, development, and performance of a novel multidose dry-powder inhaler.Pharm Technol 1999; 23(10):70–81., [CSA]
  • Borgström L. The importance of the device in asthma therapy.Respir Med 2001; 95(suppl 1):S26–S29. [CSA]
  • Godfrey C, Buck H, Ellis S. Bioavailability of budesonide delivered by the Clickhaler and Turbuhaler dry powder inhalers in healthy volunteers: a pilot study.Clin Drug Investig 2002; 22(2):119–124. [CSA]
  • Everard M, Ellis S, Das S. Comparison of the efficacy and safety of budesonide administered via the Clickhaler or Turbuhaler [abstr].Eur Respir J 2003; 22(suppl 45):311s. [CSA]
  • Hoekx J CM, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 µg/day.Eur Respir J 1996; 9(11):2263–2272. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Stradling J R, Pearson M G, Morice A H, Peake M D, Barnes N C. Efficacy and safety of a novel beclomethasone dipropionate dry powder inhaler (Clickhaler®) for the treatment of adult asthma.J Asthma 2000; 37(2):183–190. [PUBMED], [INFOTRIEVE], [CSA]
  • Adler L M, Anand C, Wright FG de L, Barrett C F, McKeith D, Clark W IC, Maksimczyk P, Martin G DR, McKinnon C, Raffles A KM, Buck H. Efficacy and tolerability of beclomethasone dipropionate delivered by a novel multidose dry powder inhaler (Clickhaler) versus a metered-dose inhaler in children with asthma.Curr Ther Res 2001; 62(11):758–769. [CSA], [CROSSREF]
  • Clinical development of drugs against asthma. Society of Pharmaceutical Medicine Expert Report.J Pharm Med 1993; 3(3/4):177–180. [CSA]
  • Langdon C G, Capsey L J, UK Study Group. Fluticasone propionate and budesonide in adult asthmatics: a comparison using dry-powder inhaler devices.Br J Clin Res 1994; 5:85–99. [CSA]
  • Chuchalin A G, Kremer H-J, Metzenauer P, O'Keefe E, Hermann R. Clinical equivalence trial on budesonide delivered either by the Novolizer® multidose dry powder inhaler or the Turbuhaler® in asthmatic patients.Respiration 2002; 69(6):502–508. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Rutherford C, Mills R, Gibson P G, Price M J. Improvement in health-related quality of life with fluticasone propionate compared with budesonide or beclomethasone dipropionate in adults with severe asthma.Respirology 2003; 8(3):371–375. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Lipworth B J, Seckl J R. Measures for detecting systemic bioavailability with inhaled and intranasal corticosteroids.Thorax 1997; 52(5):476–482. [PUBMED], [INFOTRIEVE], [CSA]
  • Cross D, Nelson S H. The role of the peak flow meter in the diagnosis and management of asthma.J Allergy Clin Immunol 1991; 87(1):120–128. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Frew A J, Langley S J, Perrin V, Hertog M GL. Effects of 4-week treatment with low-dose budesonide (100 µg BID) from a novel inhaler Airmax™ and from a conventional inhaler on bronchial hyper-responsiveness, lung function and symptoms in patients with mild asthma.Respir Med 2002; 96(7):542–547. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Tukiainen H, Rytila P, Hamalainen K M, Silvasti M SL, Keski-Karhu J. Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients.Respir Med 2002; 96(4):221–229. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cochrane G M, Horne R, Chanez P. Compliance in asthma.Respir Med 1999; 93(11):763–769. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Brennan V K, Osman L M, Graham H, Critchlow A, Everard M L. True device compliance: the need to consider both competence and contrivance.Respir Med 2005; 99(1):97–102. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Morice A H, Adler L M, Ellis S, Hewitt A. Do patients prefer dry powder inhalers or metered-dose inhalers? A retrospective combined analysis.Curr Ther Res 2002; 63(8):496–506. [CSA], [CROSSREF]
  • Symes M, Ward L, Fernandez C, Diggory P. A randomised comparison of inhaler technique among elderly people using two inhalers.Age Ageing 1999; 28(suppl 2):112. [CSA]
  • Iqbal S M, Ritson S, Buck H, Ellis S, Everard M L. Majority of children aged 3 years and above can reliably inhale through the Clickhaler.Pediatr Pulmonol 2003; 36(1):63–68. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • National Asthma Campaign. National Asthma Audit 1999/2000. Cookham, UK: Direct Publishing Solutions Ltd., 1999.
  • Newhouse M T, Patel P, Parry-Billings M. Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler DPI.Eur Respir J 2003; 21(5):816–820. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.